Bharat Biotech pursues Covid-19 vaccine approval in over 40 countries


 

India's Bharat Biotech is in the process of filing regulatory documents for approval of its COVID-19 vaccine, COVAXIN, in more than 40 countries, the company told Reuters late on Wednesday.

"We have submitted our documentation in Brazil and other countries and await their approval. We plan to export several million doses to Brazil," the company said in an emailed statement. "Pricing of COVAXIN for international markets will be based upon supply timelines, purchase commitments and procurement volumes," it added.

Bharat Biotech, which last Tuesday had told Reuters it may export doses of COVAXIN to Brazil and the United Arab Emirates by the end of the week, did not name other countries and did not give exact figures on doses it expects to export.

The company has also entered into an agreement with U.S. drug developer Ocugen Inc for the commercialization of COVAXIN in the United States, which has seen the most number of infections in the world. Read More

Comments

Popular posts from this blog

Cafe Coffee Day names S V Ranganath as interim chairman

Kohli only Indian among Forbes highest paid athletes, Messi tops the list

Mia Khalifa engaged to beau Robert Sandberg